VVA-32977-61165 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-23
Registered in v-safe
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2020-12-24
Survey response — days 1–6 daily, dose 1
MedDRA: Abnormal dreams — Feeling: Good

Free text: Weird dreams

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Nausea, Diarrhea, Abdominal pain

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Survey response — days 1–6 daily, dose 1
MedDRA: Abnormal dreams — Feeling: Good

Free text: Weird dreams

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-30
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-11
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea

Adult check-in
2021-01-12
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · Joint pains, Diarrhea

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Abnormal dreams — Feeling: Good

Free text: Weird dreams

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-20
Health check-in — day 7, dose 2
Feeling: Good · Nausea

Adult check-in
2021-01-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-22
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-12
Survey response — 3 months, dose 2
MedDRA: Acute macular neuroretinopathy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Acute Macular Neuroretinopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-10
Call 1 — Left Voicemail
2021-06-24
Call 2 — Left Voicemail
2021-07-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-11
Survey response — 12 months, dose 2
MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Pregnancy Covid

MedDRA releases: 2024-11 · check-in free text available
2022-01-11
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-01-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-12	priority 2/3
2021-04-12	Unsuccessful
2022-01-11	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-24

Systemic reaction (other): Weird dreams

2020-12-27

Systemic reaction (other): Weird dreams

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Dizziness

Release 2 — days 1–6 daily, dose 2

2021-01-17

Systemic reaction (other): Weird dreams

Release 7 — 3 months, dose 2

2021-04-12

Symptoms: Acute Macular Neuroretinopathy

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Pregnancy Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Acute macular neuroretinopathy	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Abnormal dreams	✓	✓	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release